Cui WeiDong
Direttore Tecnico/Scientifico/R&S presso JHL BIOTECH, INC.
Provenienza dei contatti di primo grado di Cui WeiDong
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Private Company | Pharmaceuticals: Major | 17 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Cui WeiDong tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| INTEL CORPORATION | Semiconductors | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| HUTCHMED (CHINA) LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
CDIB Capital Group
 CDIB Capital Group Investment ManagersFinance CDIB Capital Group engages in the venture capital, and investment banking industries. Its business activities include industrial investment, asset management, own capital investment assets, activated assets, and international investment. The company was founded in 1959 and is headquartered in Taipei, Taiwan. | Investment Managers | Corporate Officer/Principal | |
| HO TUNG CHEMICAL CORP. | Chemicals: Specialty | Director/Board Member | |
Shanghai GeneCore BioTechnologies Co., Ltd.
 Shanghai GeneCore BioTechnologies Co., Ltd. BiotechnologyHealth Technology Part of Quest Diagnostics, Inc., Shanghai GeneCore BioTechnologies Co., Ltd. engages in nucleotide synthesis, DNA sequencing, bioinformatics analysis, and mutation detection. The company is based in Shanghai, China. | Biotechnology | Director/Board Member | |
Hutchison Whampoa (China) Ltd.
 Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Part of CK Hutchison Holdings Ltd., Hutchison Whampoa (China) Ltd. is a Chinese company that provides investment services. The company is based in Hong Kong, Hong Kong. Chi Keung To has been the CEO of the company since 1980. | Financial Conglomerates | Corporate Officer/Principal | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree | |
| Kent State University (Ohio) | College/University | Doctorate Degree | |
| University of British Columbia | College/University | Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Cincinnati (Ohio) | College/University | Doctorate Degree | |
| University of Vienna | College/University | Doctorate Degree | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
| National Taiwan University | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Pharmaceuticals: Major | Director of Finance/CFO | |
Nomura International (Hong Kong) Ltd.
 Nomura International (Hong Kong) Ltd. Investment Banks/BrokersFinance Nomura International (Hong Kong) Ltd. (Nomura International HK) is the brokerage subsidiary of Nomura Asia Pacific Holdings Co. Ltd., which is ultimately-owned by Nomura Holdings, Inc. (TYO: 8604) in Japan. Headquartered in Hong Kong, the firm’s global markets team offers research, sales and trading of global securities to a diverse range of clients globally, including institutional investors, financial institutions, corporates, financial sponsors and government entities. Nomura International HK operates a truly integrated, cross-asset platform which includes research, sales and trading in equities, currencies, rates and credit in cash and derivative products. | Investment Banks/Brokers | Corporate Officer/Principal | |
Shanghai University of Finance & Economics
 Shanghai University of Finance & Economics Other Consumer ServicesConsumer Services Shanghai University of Finance and Economics engages in the provision of educational services. It offers courses under the following school and departments: business, accountancy, finance, international business administration, economics, public economics and administration, humanities, law, information management and engineering, statistics, foreign languages, mathematics, international cultural exchange, professional and international education and continuing education. The company was founded in 1917 and is headquartered in Shanghai, China. | College/University | Doctorate Degree | |
Merrill Lynch (Asia Pacific) Ltd.
 Merrill Lynch (Asia Pacific) Ltd. Investment ManagersFinance Merrill Lynch (Asia Pacific) Ltd. (Merrill Lynch-Asia Pacific) is the financial management subsidiary of Merrill Lynch HK Services, Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. Based in Hong Kong, the firm provides financial management and advisory services. | Investment Managers | Corporate Officer/Principal | |
Citigroup Global Markets Asia Ltd.
 Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Investment Banks/Brokers | Corporate Officer/Principal | |
| WUXI APPTEC CO., LTD. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Loyola Law School | College/University | Graduate Degree | |
Development Center for Biotechnology
 Development Center for Biotechnology Medical/Nursing ServicesHealth Services The Development Center for Biotechnology of Taiwan is a nonprofit organization co-sponsored by government grants and private donations. It focuses on biotechnology and pharmaceutical industry. The company was founded in 1984 and is headquartered in Taipei, Taiwan. | Medical/Nursing Services | Director/Board Member Chief Executive Officer | |
CytoPharm, Inc.
 CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Pharmaceuticals: Major | Director/Board Member | |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Medical Specialties | Chief Executive Officer | |
Vita Genomics, Inc.
 Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Medical/Nursing Services | Chief Executive Officer | |
| PHARMIGENE, INC. | Pharmaceuticals: Generic | Director/Board Member | |
DuPont Taiwan Ltd.
 DuPont Taiwan Ltd. Agricultural Commodities/MillingProcess Industries Founded in 1968, DuPont Taiwan Ltd. is a subsidiary of DuPont de Nemours, Inc. that manufactures animal nutrition feeding products. The company is based in HsinChu, Taiwan. | Agricultural Commodities/Milling | Corporate Officer/Principal | |
| Ya Tung Investment Co. Ltd. | Director/Board Member | ||
| HAKERS ENTERPRISE CO., LTD. | Apparel/Footwear | Director/Board Member | |
| Chia-Ho Co., Ltd. | Chairman | ||
| Chi-Chi Co. Ltd. | Chairman | ||
Chia He Investment Co. Ltd.
 Chia He Investment Co. Ltd. Financial ConglomeratesFinance Chia He Investment Co. Ltd. operates as an investment holding Taiwanese company. | Financial Conglomerates | Chairman | |
| OBI PHARMA, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Columbia Business School | College/University | Masters Business Admin | |
| Merit Ocean Biotech, Inc. | Chairman | ||
| Yurun Merit Biotech (Lianyungang) Co. Ltd. | Director/Board Member | ||
| Bradford University School of Management | College/University | Graduate Degree | |
| POLARIS GROUP | Biotechnology | Director/Board Member | |
| FORESEE PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| UNIPHARMA CO., LTD. | Medical Distributors | Director/Board Member | |
| Yuan He Biotech Co. Ltd. | Director/Board Member | ||
| Chenergy Co. Ltd. | Director/Board Member | ||
| MERIT BIOTECH INC | Pharmaceuticals: Major | Chairman | |
| ZAI LAB LIMITED | Biotechnology | Founder Chief Executive Officer |
Statistiche
Distribuzione geografica
| Taiwan | 22 |
| Stati Uniti | 15 |
| Cina | 7 |
| Hong Kong | 6 |
| Canada | 2 |
Settori
| Health Technology | 19 |
| Consumer Services | 12 |
| Finance | 7 |
| Process Industries | 3 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 69 |
| Corporate Officer/Principal | 28 |
| Chairman | 19 |
| Independent Dir/Board Member | 13 |
| Undergraduate Degree | 12 |
Contatti più connessi
| Insiders | |
|---|---|
| Zuie Chin Huang | 40 |
| Yi Hsiung Chen | 24 |
| Bryant Fong | 23 |
| Max Chan | 16 |
| Chia Lin Wang | 10 |
| Ying Du | 9 |
| Ellis Chu | 8 |
| Jun Wu | 7 |
| Raco Ivan Jordanov | 5 |
| Rong Chen | 4 |
| DJ Lin | 3 |
| Rose Lin | 2 |
| Fang Hsi Teng | 2 |
| Andreas Nechansky | 2 |
| Peter Pang | 2 |
- Borsa valori
- Insiders
- Cui WeiDong
- Connessioni Società
